We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+16.53%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$6.64M
Cap. Flow
-$8.72M
Cap. Flow %
-4.75%
Top 10 Hldgs %
35.79%
Holding
86
New
25
Increased
22
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.21M
3
DHR icon
Danaher
DHR
+$2.92M
4
XLRN
Acceleron Pharma
XLRN
+$2.43M
5
ESPR
Esperion Therapeutics
ESPR
+$2.41M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$6.61M
2
AGN
Allergan plc
AGN
+$6.08M
3
SPNC
Spectranetics Corp
SPNC
+$4.22M
4
SNY icon
Sanofi
SNY
+$3.59M
5
CELG
Celgene Corp
CELG
+$3.06M

Sector Composition

Rank Sector Weight
1 Healthcare 76.63%
2 Financials 2.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$10.9M 5.96%
75,000
-22,500
-23% -$3.06M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$7.52M 4.1%
150,000
+50,000
+50% +$2.41M
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$6.99M 3.81%
500,000
+175,000
+54% +$1.74M
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$6.59M 3.59%
80,000
+5,000
+7% +$396K
BIIB icon
5
Biogen
BIIB
$30B
$6.26M 3.41%
20,000
+12,500
+167% +$3.7M
CLVS
6
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$6.18M 3.37%
+75,000
New +$5.95M
ABBV icon
7
AbbVie
ABBV
$443B
$5.78M 3.15%
65,000
+25,000
+63% +$1.9M
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$5.61M 3.06%
40,000
-20,000
-33% -$2.72M
CI icon
9
Cigna
CI
$73.7B
$4.95M 2.7%
26,500
+9,000
+51% +$1.6M
AERI
10
DELISTED
Aerie Pharmaceuticals
AERI
$4.86M 2.65%
100,000
+5,000
+5% +$273K
MRK icon
11
Merck
MRK
$322B
$4.8M 2.62%
78,600
-5,240
-6% -$318K
ABT icon
12
Abbott
ABT
$183B
$4.54M 2.47%
85,000
+45,000
+113% +$2.26M
AET
13
DELISTED
Aetna Inc
AET
$4.53M 2.47%
28,500
-4,000
-12% -$625K
KPTI icon
14
Karyopharm Therapeutics
KPTI
$43.5M
$4.39M 2.39%
26,667
+6,667
+33% +$955K
KTWO
15
DELISTED
K2M Group Holdings, Inc
KTWO
$4.24M 2.31%
200,000
– –
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.88M 2.11%
125,000
-50,000
-29% -$1.41M
MDCO
17
DELISTED
Medicines Co
MDCO
$3.7M 2.02%
100,000
-50,000
-33% -$1.84M
BSX icon
18
Boston Scientific
BSX
$69.5B
$3.65M 1.99%
125,000
+70,000
+127% +$1.93M
ZBH icon
19
Zimmer Biomet
ZBH
$18.2B
$3.51M 1.91%
30,900
+5,150
+20% +$594K
BMY icon
20
Bristol-Myers Squibb
BMY
$133B
$3.51M 1.91%
+55,000
New +$3.21M
LLY icon
21
Eli Lilly
LLY
$1.02T
$3.42M 1.86%
40,000
-10,000
-20% -$820K
DERM
22
DELISTED
Dermira, Inc.
DERM
$3.38M 1.84%
125,000
-15,000
-11% -$393K
JUNO
23
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.37M 1.83%
75,000
-25,000
-25% -$852K
GKOS icon
24
Glaukos
GKOS
$9.83B
$3.3M 1.8%
100,000
+40,000
+67% +$1.52M
TSRO
25
DELISTED
TESARO, Inc.
TSRO
$3.23M 1.76%
25,000
+10,000
+67% +$1.24M
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2017 Portfolio in Review

As of Q3 2017, Iguana Healthcare Management held 86 positions worth $184M, up 3.8% from $177M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Iguana Healthcare Management withdrew a net $8.72M in Q3 2017, closing 18 positions and reducing 18 holdings. Its most notable exit was Shire pic, an estimated $6.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Financials.

Against the trend, Iguana Healthcare Management opened a new position in Bristol-Myers Squibb worth $3.51M.

  • Iguana Healthcare Management's largest Q3 2017 buy was Bristol-Myers Squibb: 55,000 shares worth $3.51M.
  • Iguana Healthcare Management added most to Biogen in Q3 2017, an estimated $3.7M increase.
  • Iguana Healthcare Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $3.06M.
  • Iguana Healthcare Management fully exited Shire pic in Q3 2017, selling an estimated $6.61M.
  • Iguana Healthcare Management's ten largest holdings make up 36% of its $184M portfolio in Q3 2017.
  • Iguana Healthcare Management opened 25 new positions and closed 18 in Q3 2017.
  • Iguana Healthcare Management's portfolio value rose 3.8% quarter-over-quarter to $184M.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.